Use of Erdafitinib in FGFR3-Mutated Recurrent Respiratory Papillomatosis
Year: 2022
Type: article
Study design: Case Report
Source: JCO Precision Oncology
DOI: 10.1200/po.22.00435
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310703114
